one
singlenucleotid
polymorph
gene
signific
pool
respiratori
infect
also
detect
associ
gene
tuberculosi
subset
analys
identifi
addit
risk
factor
tuberculosi
axi
could
highli
interest
target
translat
toward
clinic
use
howev
conclus
base
low
credibl
evid
almost
identifi
studi
strong
risk
bia
confound
futur
studi
must
build
upon
largerscal
collabor
also
strictli
adher
highest
evidencebas
principl
studi
design
order
reduc
research
wast
provid
clinic
translat
evid
hypothesisfre
approach
like
genomewid
associ
studi
manag
spark
progress
field
indic
lack
replic
result
studi
unfortun
insight
deriv
field
clinic
infectolog
microbiolog
immunolog
epidemiolog
well
clinic
evolutionari
popul
genet
remain
larg
isol
one
anoth
prevent
systemat
understand
entir
field
interest
host
factor
associ
respiratori
infecti
diseas
stem
abil
caus
epidem
pandem
infam
spanish
influenza
implic
largest
ever
record
pandem
caus
estim
million
death
hand
tuberculosi
exampl
highli
adapt
pathogen
manag
coevolv
human
possibl
far
initi
wave
human
migrat
africa
estim
suggest
million
peopl
suffer
global
million
attribut
death
annual
possibl
much
third
live
human
latent
carrier
pneumonia
remain
one
main
childhood
mortal
caus
estim
million
episod
million
lethal
outcom
global
similarli
respiratori
syncyti
viru
rsv
attribut
million
episod
newli
diagnos
acut
lower
respiratori
infect
worldwid
children
year
least
million
episod
sever
case
requir
hospit
admiss
final
sarscoronaviru
outbreak
exampl
quickli
novel
respiratori
pathogen
spread
global
scale
understand
host
genet
side
could
invalu
tool
clinic
medicin
especi
suscept
infecti
agent
lie
least
partli
hidden
mask
inborn
error
immun
respons
render
infecti
diseas
highrank
research
prioriti
mind
mobil
modern
human
popul
ever
chang
pathogen
natur
therefor
aim
studi
provid
field
synopsi
systemat
review
metaanalys
host
genet
suscept
respiratori
infecti
diseas
special
focu
set
compar
analysi
differ
clinic
present
pathogen
aim
increas
understand
share
specif
diseas
pathway
could
identifi
basi
previous
publish
candid
gene
studi
also
provid
critic
overview
entir
field
gener
framework
improv
futur
studi
infectom
applic
genom
proteom
metabolom
omic
technolog
understand
infecti
diseas
develop
progress
outcom
total
data
point
extract
studi
major
data
address
tuberculosi
data
point
follow
rsv
sarscoronaviru
influenza
pneumonia
rest
respiratori
infect
otiti
media
bronchiti
differ
gene
data
frequent
result
tnfa
total
distinct
marker
record
databas
met
inclus
criteria
least
four
data
point
avail
per
marker
use
subsequ
metaanalysi
data
point
three
csi
score
domain
score
data
point
credibl
csi
score
b
grade
remain
data
point
least
one
c
grade
thu
consid
weak
credibl
fig
diseasespecif
csi
profil
indic
better
qualiti
studi
pneumonia
influenza
tuberculosi
csi
score
lower
case
sarscoronaviru
respiratori
syncyti
viru
rsv
supplementari
figur
among
investig
data
point
total
attribut
infecti
diseas
suscept
diseas
sever
compar
sever
vs
mild
diseas
case
mortal
remain
studi
base
comparison
tuberculosi
skintest
posit
result
control
perform
total
diseas
suscept
metaanalysi
four
genet
model
total
nomin
signific
result
supplementari
tabl
howev
two
gene
retain
noteworthi
midlow
bfdp
level
tabl
signific
result
sever
model
supplementari
tabl
perform
mortal
metaanalysi
due
lack
least
four
publish
studi
marker
identifi
total
famili
linkagebas
studi
includ
metaanalysi
due
methodolog
restraint
studi
cover
either
broad
genom
region
chromosom
x
specif
gene
spa
spd
gene
supplementari
tabl
also
identifi
gwa
studi
seven
tuberculosi
three
otiti
media
one
influenza
two
genomewid
signific
result
record
tuberculosi
belong
gene
gene
supplementari
tabl
also
identifi
publish
metaanalys
major
address
genet
suscept
tuberculosi
howev
metaanalys
investig
scientif
report
doi
infect
suscept
much
wider
set
clinic
appear
often
manifest
restrict
respiratori
tract
thu
directli
compar
studi
first
extens
systemat
review
metaanalysi
publish
studi
address
host
genet
factor
implic
five
common
respiratori
tract
infecti
diseas
tuberculosi
influenza
respiratori
syncyti
viru
rsv
sarscoronaviru
pneumonia
major
publish
studi
metaanalys
base
one
pathogen
one
polymorph
approach
focus
pathogen
suscept
hand
publish
studi
compar
differ
respiratori
tract
diseas
addit
major
previous
publish
metaanalys
address
tuberculosi
none
found
sarscoronaviru
rsv
influenza
therefor
develop
entir
resourc
enabl
diseasespecif
analys
also
analys
share
pool
infecti
diseas
mechan
respiratori
system
stringent
evidencebas
manner
total
found
two
result
withstood
multipl
test
correct
pool
model
tuberculosi
addit
establish
role
tuberculosi
includ
subset
methodolog
better
studi
control
known
exposur
previous
describ
pivot
role
shape
natur
immun
respons
promot
stimul
tcell
bcell
differenti
provid
balanc
respons
therefor
alter
function
may
substanti
affect
immun
respons
commonli
report
alter
associ
increas
risk
atopi
allergi
furthermor
seem
direct
role
infecti
diseas
outcom
mice
suscept
legionella
pneumophila
increas
mortal
rate
compar
control
singl
result
signific
pool
analys
margin
diseasespecif
metaanalys
reflect
need
studi
statist
power
also
suggest
one
like
translat
result
toward
clinic
applic
across
wider
spectrum
respiratori
infecti
diseas
member
larg
famili
gene
involv
pathogen
recognit
signal
cascad
innat
immun
respons
previou
studi
suggest
role
suscept
tuberculosi
also
bacteria
mycoplasma
mycobacterium
neisseria
gramposit
bacteria
interestingli
despit
close
link
mechan
result
studi
show
associ
tuberculosi
strong
result
odd
ratio
find
could
point
toward
specif
role
tuberculosi
weaker
associ
even
lack
associ
element
immun
respons
interestingli
effect
seem
contextspecif
absenc
knockout
mice
affect
clinic
outcom
seem
role
secondari
infect
suggest
exact
mechan
function
still
elus
focus
studi
need
take
account
exact
pathophysiolog
process
patient
tuberculosi
gene
associ
diseas
includ
monocyt
infiltr
migrat
retent
monocyt
particular
locat
consequ
granuloma
format
role
tuberculosi
describ
previous
notabl
ethnicspecif
differ
studi
gene
signific
subset
analysi
studi
exclus
expos
control
subselect
clearli
demonstr
methodolog
improv
posit
effect
gene
discoveri
complex
genet
architectur
infecti
diseas
develop
coupl
error
omiss
primari
studi
design
might
explain
accumul
larg
amount
poorli
usabl
evid
therefor
one
main
conclus
studi
best
way
forward
improv
primari
studi
reduct
research
wast
overview
famili
linkagebas
studi
suggest
frequent
differ
studi
design
mark
dissimilar
phenotyp
definit
marker
type
analyt
approach
nevertheless
associ
tuberculosi
replic
two
studi
notabl
except
third
one
supplementari
tabl
overlap
candidategen
studi
gwa
thu
prohibit
compar
analysi
gwa
studi
provid
two
signific
replic
result
locat
intergen
region
near
gene
gene
report
signal
replic
independ
cohort
supplementari
tabl
like
consequ
larg
underpow
studi
design
sampl
size
rare
exceed
case
control
importantli
methodolog
problem
carri
candidategen
studi
design
upscal
studi
term
genet
resolut
singl
marker
marker
thousand
hundr
thousand
marker
gwa
increas
sampl
size
use
advanc
analyt
method
like
provid
substanti
step
forward
manag
overcom
methodolog
studi
design
limit
addit
face
high
level
genet
complex
dualiti
rare
mendelian
variant
may
confer
complet
immun
low
preval
popul
common
variant
usual
much
lower
explain
varianc
therefor
limit
capac
clinic
intervent
princip
step
forward
creat
largerscal
collabor
enabl
data
share
built
upon
common
framework
analysi
base
align
protocol
largerscal
harmon
collabor
effort
result
studi
fit
previous
impli
mechan
respiratori
infect
axi
describ
critic
role
product
immun
respons
regul
fungal
viral
infect
well
atherosclerosi
tumour
despit
differ
describ
vitro
vivo
studi
could
interest
translat
mechan
toward
clinic
medicin
addit
gene
gwa
studi
impli
suscept
tuberculosi
describ
control
seem
targetrespons
cytocid
activ
mechan
mechan
could
least
partli
explain
relationship
infect
tumour
howev
clarifi
relationship
provid
step
forward
must
firstli
abl
deriv
much
better
evid
primari
studi
primari
studi
design
one
main
barrier
field
develop
almost
extract
data
point
assess
strong
risk
bia
confound
improv
must
embodi
evidencebas
principl
undertaken
almost
domain
field
includ
better
clinic
definit
phenotyp
improv
control
select
diagnost
appropri
statist
analysi
favour
studi
design
use
novel
molecular
technolog
scientif
report
doi
better
report
larger
sampl
size
obtain
consortia
develop
firstli
need
improv
phenotyp
definit
criteria
diagnosi
especi
case
latent
tuberculosi
use
proxi
extrem
phenotyp
seen
hiv
expos
uninfect
subject
longterm
nonprogressor
fast
progressor
elit
control
might
also
provid
interest
step
forward
common
author
use
term
healthi
control
almost
univers
use
dissimilar
diagnost
process
classif
case
control
thu
select
control
diagnost
process
must
fundament
improv
harmon
supplementari
tabl
substanti
effort
must
go
toward
inclus
control
expos
pathogen
necessari
diseas
develop
may
suffici
data
analysi
must
also
improv
adher
best
practic
includ
use
report
odd
ratio
confid
interv
measur
associ
multipl
test
correct
improv
made
studi
design
avail
fine
phenotyp
lifelong
cohort
biobank
provid
opportun
use
data
understand
lifelong
risk
develop
respiratori
infecti
diseas
tuberculosi
use
novel
molecular
technolog
variou
omic
applic
infecti
diseas
develop
progress
outcom
infectom
present
unpreced
opportun
field
howev
must
base
evidencebas
alway
includ
estim
repeat
focu
replic
effort
unlink
popul
lastli
must
substanti
improv
result
report
refer
structur
manuscript
prepar
report
relev
inform
manuscript
prepar
given
set
criteria
like
strega
strobem
strei
appropri
also
extend
need
develop
individualdata
public
repositori
creation
largescal
consortia
share
common
standardoper
procedur
similarli
chronic
diseas
genet
epidemiolog
neglect
propos
finer
scale
analys
variou
popul
subset
consid
improv
studi
design
much
stronger
potenti
impact
suggest
applic
genom
also
type
infectom
studi
defin
applic
variou
omic
technolog
understand
infecti
diseas
develop
progress
outcom
addit
need
start
develop
framework
systemat
review
need
compar
diseasespecif
gene
pathway
diseasespecif
gene
final
outcom
clinic
diseas
might
attribut
differ
set
gene
make
person
suscept
eg
pneumonia
regardless
pathogen
caus
compar
complementari
result
insight
abl
better
understand
har
inform
clinic
care
result
must
view
light
numer
limit
review
divers
field
unifi
report
scheme
suggest
search
might
miss
relev
articl
data
sourc
order
accommod
problem
perform
extens
search
supplement
handsearch
procedur
describ
materi
method
section
exist
widerscal
unpublish
data
occasion
inabl
obtain
raw
data
present
anoth
possibl
sourc
bia
studi
also
suffer
limit
input
due
exclus
hla
kir
marker
haplotyp
complet
omiss
inform
pathogen
thu
provid
rather
limit
insight
field
possibl
miss
key
element
indepth
understand
limit
neg
impact
effecttobia
ratio
bia
may
sever
order
magnitud
greater
size
effect
attempt
contrast
use
stringent
analyt
approach
evidencebas
manner
includ
multipl
test
correct
care
applic
inclus
criteria
qualiti
assess
score
coupl
use
randomeffect
metaanalysi
studi
also
suffer
inabl
adjust
analysi
basic
covari
age
sex
comorbid
inform
also
use
novel
score
qualiti
assess
develop
within
studi
valid
thu
provid
basic
agreement
indic
wider
use
score
would
requir
indepth
reliabl
assess
valid
turn
back
biolog
process
earlier
primari
studi
ignor
microbiom
novel
studi
suggest
lung
steril
respiratori
tract
microbiom
could
strong
modifi
effect
health
diseas
mechan
despit
limit
attempt
provid
field
synopsi
supplement
gener
framework
could
use
respiratori
infecti
diseas
genet
extend
infecti
diseas
howev
result
first
step
attempt
provid
reflect
one
side
infecti
diseas
stori
host
combin
host
genom
omic
inform
pathogen
omic
abl
truli
advanc
field
enabl
develop
person
infecti
diseas
medicin
protocol
registr
review
strategi
detail
regist
prospect
prospero
record
elig
criteria
undertook
extens
systemat
search
publish
studi
relat
host
genet
implic
develop
outcom
respiratori
tract
infecti
diseas
instead
focus
singlediseas
approach
aim
deliv
systemat
evid
respiratori
infect
includ
case
syndrom
phenotyp
report
pneumonia
without
specif
pathogen
inform
scientif
report
doi
inform
sourc
use
three
bibliograph
databas
pubm
http
wwwncbinlmnihgov
pubm
web
scienc
http
wokmimasacuk
scopu
http
wwwscopuscom
also
perform
addit
search
huge
literatur
finder
http
wwwhugenavigatornet
identifi
articl
might
miss
pubm
search
two
joint
first
author
perform
search
studi
select
supervis
last
author
last
author
also
resolv
discrep
score
system
data
extract
process
search
perform
may
updat
perform
august
duplic
remov
search
yield
total
articl
identifi
articl
firstli
check
inclus
read
titl
abstract
led
identif
exclus
total
studi
remain
articl
supplement
hand
search
refer
produc
addit
set
articl
total
use
set
articl
read
full
screen
inclus
criteria
supplementari
figur
studi
select
process
base
iter
step
firstli
studi
need
report
number
case
control
everi
analys
genotyp
therefor
initi
exclud
familybas
linkag
studi
well
genomewid
associ
gwa
studi
metaanalysi
due
inabl
obtain
complet
set
gwa
result
appropri
format
howev
retain
studi
provid
qualit
summari
order
develop
inclus
field
synopsi
secondli
studi
base
biallel
singlenucleotid
polymorph
snp
biallel
insertiondelet
marker
type
studi
base
marker
type
includ
microsatellit
short
tandem
repeat
report
aggreg
haplotyp
exclud
also
exclud
studi
report
exclus
gene
express
profil
without
relev
genotyp
inform
limit
review
studi
publish
year
written
english
languag
despit
similar
diseas
pattern
mechan
exclud
anim
vitro
studi
focus
suscept
previous
healthi
subject
also
exclud
studi
report
outcom
previous
affect
patient
either
part
immunodefici
syndrom
form
diseas
asthma
hivaid
comorbid
report
fungal
infect
due
also
preval
comorbid
nosocomi
infect
ventilatorrel
hospitalacquir
pneumonia
exclus
pathogen
genotyp
hostpathogen
interact
studi
report
nonrespiratori
infect
site
extrapulmonari
tuberculosi
mening
invas
pneumococc
diseas
also
exclud
focu
studi
respiratori
infecti
diseas
lastli
exclud
studi
obvious
report
previous
publish
result
reus
case
alreadi
use
elsewher
manag
identifi
order
remov
redund
data
public
metaanalysi
ensur
systemat
sourc
inform
addit
check
studi
provid
insuffici
inform
total
email
sent
author
studi
classifi
report
insuffici
inform
ask
clarif
raw
data
share
also
contact
author
identifi
gwa
studi
share
result
entir
process
result
total
respons
reject
respons
meet
inclus
criteria
case
clarif
share
raw
data
list
acknowledg
total
use
articl
data
extract
process
supplementari
figur
data
collect
process
data
item
total
piec
inform
extract
everi
studi
avail
onlin
risedb
respiratori
infect
suscept
databas
avail
http
wwwprepareeuropeeurisedb
data
extract
enter
databas
two
author
check
third
order
ensur
data
integr
identifi
studi
index
uniqu
identif
code
risedb
id
studi
provid
one
data
point
correspond
one
marker
one
studi
data
entri
consequ
repres
one
data
entri
databas
instanc
data
extract
raw
format
genotyp
count
calcul
report
percentag
total
sampl
size
number
case
control
avail
case
control
group
avail
one
studi
either
pool
retain
multipl
data
point
studi
especi
case
discoveri
replic
dataset
addit
data
point
classifi
accord
underli
research
question
three
categori
studi
investig
infecti
diseas
suscept
diseas
sever
diseas
mortal
addit
defin
subset
methodolog
better
studi
control
known
exposur
pathogen
develop
novel
score
purpos
risk
bia
assess
methodolog
design
defin
studi
may
prone
three
main
domain
error
bia
confound
select
bia
inform
bia
three
domain
basi
score
develop
entitl
confoundingselectioninform
bia
score
csi
supplementari
tabl
element
score
develop
basi
sever
previou
studi
assess
score
includ
venic
criteria
assess
cumul
epidemiolog
evid
genet
associ
newcastleottawa
casecontrol
scale
cochran
risk
bia
tool
previous
establish
qualiti
score
genet
epidemiolog
neither
tool
provid
good
fit
risk
bia
assess
observ
studi
genet
epidemiolog
therefor
took
element
previou
scale
deriv
new
one
line
venic
criteria
score
three
domain
three
grade
credibl
high
grade
intermedi
b
weak
c
scheme
provid
estim
rang
best
aaa
worst
ccc
score
appli
everi
data
point
rise
databas
metaanalysi
result
venic
criteria
intend
sinc
inform
bia
affect
sever
aspect
studi
also
divid
inform
bia
risk
domain
three
separ
subscor
relat
case
control
select
genotyp
procedur
worst
three
defin
overal
inform
bia
risk
csi
score
done
independ
two
author
discrep
settl
agreement
input
third
author
data
point
initi
dissimilar
grade
provid
good
agreement
kappa
coeffici
standard
error
kappa
addit
qualiti
control
check
recalcul
hardyweinberg
test
everi
control
set
includ
analysi
use
two
tail
chisquar
test
exact
test
appropri
data
point
fail
hwe
test
level
p
downgrad
c
csi
score
analys
data
point
fail
hwe
order
reflect
possibl
methodolog
limit
fail
hwe
indic
risk
select
andor
inform
bia
case
singl
studi
classifi
moder
sever
determin
select
domain
csi
score
total
data
point
instanc
assign
select
bia
risk
select
process
involv
secondstag
analysi
perform
summari
measur
synthesi
result
first
step
metaanalysi
calcul
odd
ratio
anew
raw
data
order
provid
common
analyt
framework
reduc
possibl
differ
data
analysi
order
better
understand
genet
architectur
underli
genediseas
associ
perform
analys
use
four
separ
genet
model
allel
domin
recess
heterozygot
advantag
model
select
base
commonli
use
allel
model
two
addit
model
assum
differ
inherit
effect
domin
recess
follow
heterozygot
advantag
previou
studi
report
result
calcul
therefor
base
allel
count
rather
exact
case
control
count
compar
result
differ
model
attempt
provid
broader
insight
genet
architectur
minor
allel
frequenc
homo
sapien
short
variat
data
set
obtain
ensembl
biomart
perform
seri
metaanalys
snp
four
data
point
avail
singl
snp
use
random
effect
metaanalysi
assum
differ
design
ethnic
composit
individu
studi
also
calcul
fixedeffect
model
order
compar
result
use
statist
correspond
confid
interv
measur
heterogen
order
account
multipl
test
result
numer
metaanalys
differ
genet
model
perform
use
bayesian
falsediscoveri
probabl
bfdp
calcul
nomin
signific
result
threshold
use
onlin
free
version
bfdp
calcul
http
facultywashingtonedujonnobfdpxl
addit
calcul
bfdp
use
two
prior
probabl
mediumlow
prior
level
consist
candid
gene
low
prior
level
consist
random
snp
advantag
approach
commonli
use
correct
depend
number
test
perform
reli
odd
ratio
confid
interv
calcul
addit
provid
conceptu
improv
similar
method
falseposit
report
probabl
fprp
due
substanti
requir
appropri
use
public
bia
analysi
method
examin
public
bia
visual
analys
perform
r
version
metaanalysi
perform
packag
meta
metabin
forest
funnel
function
hardyweinberg
equilibrium
test
perform
packag
hwexactmat
hwchisqmat
function
base
cell
expect
frequenc
risk
bia
across
studi
purpos
metaanalysi
credibl
assess
use
venic
criteria
instanc
nomin
signific
result
studi
power
assess
basi
sampl
size
sampl
size
grade
c
grade
b
grade
heterogen
base
statist
grade
case
b
case
c
case
third
score
domain
fix
c
weak
credibl
due
preval
risk
bia
primari
studi
